These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4289502)

  • 1. Immunization of guinea pigs with foot-and-mouth disease virus subjected to photodynamic inactivation.
    Espensen L
    Acta Pathol Microbiol Scand; 1966; 68(4):585-91. PubMed ID: 4289502
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the inactivation and antigenicity of foot-and-mouth-disease virus by acetylethyleneimine and by combined effect of ultraviolet light and beta-propiolactone.
    Fellowes ON
    J Immunol; 1965 Dec; 95(6):1100-6. PubMed ID: 4285068
    [No Abstract]   [Full Text] [Related]  

  • 3. [UV-irradiation of the foot-and-mouth disease virus. 1. Inactivation in relation to the concentration and purity of the virus and quantal yield at 2537 Angstrom].
    Liebermann H
    Arch Exp Veterinarmed; 1972 Oct; 26(5):835-46. PubMed ID: 4353314
    [No Abstract]   [Full Text] [Related]  

  • 4. A study of the physical properties of the immunizing antigen of foot-and-mouth disease virus and the effect of various inactivating agents on its structure.
    Wild TF; Brown F
    Arch Gesamte Virusforsch; 1968; 24(1):86-103. PubMed ID: 4301974
    [No Abstract]   [Full Text] [Related]  

  • 5. [The inactivation of foot-and-mouth disease virus by ethylethyleneimine and the use of the inactivated virus in the preparation of vaccines].
    Bauer K
    Zentralbl Bakteriol Orig; 1970 Apr; 213(3):285-97. PubMed ID: 4318509
    [No Abstract]   [Full Text] [Related]  

  • 6. [Foot-and-mouth virus component responsible for immunogenesis].
    Salazhov EL; Ivanov VS
    Veterinariia; 1970 Sep; 9():38-40. PubMed ID: 4323895
    [No Abstract]   [Full Text] [Related]  

  • 7. Derivatives of aziridine as inactivants for foot-and-mouth disease virus vaccines.
    Warrington RE; Cunliffe HR; Bachrach HL
    Am J Vet Res; 1973 Aug; 34(8):1087-91. PubMed ID: 4356910
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of acetylethyleneimine upon a strain of inactivated foot-and-mouth disease virus stored at 4 degrees C.
    Staple RF; Morrow AW; Fletton BW
    Arch Virol; 1975; 47(4):331-5. PubMed ID: 166627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some experiences with chemical inactivants of foot-and-mouth disease virus.
    Fellowes ON
    J Immunol; 1967 Sep; 99(3):508-13. PubMed ID: 4293089
    [No Abstract]   [Full Text] [Related]  

  • 10. [Analysis of the immunologic properties of foot-and-mouth disease vaccines].
    Tekerlekov P; Gergov P; Nikolova E
    Vet Med Nauki; 1982; 19(3):29-34. PubMed ID: 6291225
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy testing of anti-foot-and-mouth disease vaccines in guinea pigs using myotropic strains].
    Eissner G; Böhm HO
    Dev Biol Stand; 1976; 35():279-83. PubMed ID: 198295
    [No Abstract]   [Full Text] [Related]  

  • 12. [The use of diethylaminoethyl-dextran (DEAE-D) as adjuvant for immunization of guinea pigs with inactivated foot-and-mouth disease (FMD) virus].
    Wittmann G
    Zentralbl Bakteriol Orig; 1970; 213(1):1-8. PubMed ID: 4318268
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of mitomycin C, actinomycin D and ultraviolet light on the replication of the viruses of foot-and-mouth disease and vesicular stomatitis.
    Black DN; Brown F
    J Gen Virol; 1968 Dec; 3(3):453-7. PubMed ID: 4304234
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of gamma radiation on the infectivity, antigenicity and immunogenicity of the foot-and-mouth disease virus].
    Frescura T; Massa D; Cardaras P
    Boll Ist Sieroter Milan; 1972; 51(2):109-17. PubMed ID: 4345590
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and efficacy of foot-and-mouth disease vaccines containing endonuclease-inactivated virions.
    Amadori M; Barei S; Melegari M; Panina GF
    Vaccine; 1987 Sep; 5(3):219-22. PubMed ID: 2823495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The antigenic and immunologic properties and relations of A subtypes of the foot-and-mouth disease virus. II. After vaccination of guinea pigs with formalin-adsorbate].
    Wittmann G
    Zentralbl Veterinarmed B; 1966 Aug; 13(4):321-33. PubMed ID: 4292121
    [No Abstract]   [Full Text] [Related]  

  • 17. Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production.
    Bahnemann HG
    Arch Virol; 1975; 47(1):47-56. PubMed ID: 167679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antigenic and immunological relationships between the A sub-types of the foot-and-mouth disease virus. 1. After inoculation of guinea-pigs with active virus].
    Wittmann G
    Zentralbl Veterinarmed B; 1966 Jun; 13(3):225-38. PubMed ID: 4290978
    [No Abstract]   [Full Text] [Related]  

  • 19. [Testing of the activity of anti-foot-and-mouth disease vaccines].
    Fédida M; Dannacher G; Coudert M; Perrin M; Martel JL
    Dev Biol Stand; 1976; 35():243-70. PubMed ID: 198292
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of peptides for immunization against foot-and-mouth disease.
    Brown F
    Vaccine; 1988 Apr; 6(2):180-2. PubMed ID: 2838987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.